Report Summary
Eternity Insights has published a new study on Global Gastrointestinal Cancer Drugs Market focusing on key segments as by Type (Oncology, Radiology, Others), by Application (Hospitals, Specialized Cancer Treatment Centers, Clinics, Ambulatory Surgical Centers), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Gastrointestinal Cancer Drugs Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Gastrointestinal Cancer Drugs Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Gastrointestinal Cancer Drugs Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Gastrointestinal Cancer Drugs Market Segmentation:
Gastrointestinal Cancer Drugs Market, By Type
- Oncology
- Radiology
- Others
Gastrointestinal Cancer Drugs Market, By Application
- Hospitals
- Specialized Cancer Treatment Centers
- Clinics
- Ambulatory Surgical Centers
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Gastrointestinal Cancer Drugs market in terms of demand generation. The Gastrointestinal Cancer Drugs market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Gastrointestinal Cancer Drugs market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Gastrointestinal Cancer Drugs Market Taxonomy:
To learn more about this report
Global Gastrointestinal Cancer Drugs Market Competitive Landscape
The global Gastrointestinal Cancer Drugs market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Amgen Limited & Amgen Ireland Limited
- Bristol-Myers Squibb Company
- F. Hoffmann-La Roche Ltd.
- Eli Lilly and Company
- Johnson & Johnson Private Limited
- GlaxoSmithKline plc.
- Celgene Corporation
- Pfizer Inc.
- Sanofi
- Novartis AG
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Oncology, Radiology, Others |
| By Application Outlook |
Hospitals, Specialized Cancer Treatment Centers, Clinics, Ambulatory Surgical Centers |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Amgen Limited & Amgen Ireland Limited, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Johnson & Johnson Private Limited, GlaxoSmithKline plc., Celgene Corporation, Pfizer Inc., Sanofi, Novartis AG |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Gastrointestinal Cancer Drugs Market Overview
1.1 Gastrointestinal Cancer Drugs Product Overview
1.2 Gastrointestinal Cancer Drugs Market Segment by Type
1.2.1 Oncology
1.2.2 Radiology
1.2.3 Others
1.3 Global Gastrointestinal Cancer Drugs Market Size by Type
1.3.1 Global Gastrointestinal Cancer Drugs Sales and Growth by Type
1.3.2 Global Gastrointestinal Cancer Drugs Sales and Market Share by Type (2014-2019)
1.3.3 Global Gastrointestinal Cancer Drugs Revenue and Market Share by Type (2014-2019)
1.3.4 Global Gastrointestinal Cancer Drugs Price by Type (2014-2019)
2 Global Gastrointestinal Cancer Drugs Market Competition by Company
2.1 Global Gastrointestinal Cancer Drugs Sales and Market Share by Company (2014-2019)
2.2 Global Gastrointestinal Cancer Drugs Revenue and Share by Company (2014-2019)
2.3 Global Gastrointestinal Cancer Drugs Price by Company (2014-2019)
2.4 Global Top Players Gastrointestinal Cancer Drugs Manufacturing Base Distribution, Sales Area, Product Types
2.5 Gastrointestinal Cancer Drugs Market Competitive Situation and Trends
2.5.1 Gastrointestinal Cancer Drugs Market Concentration Rate
2.5.2 Global Gastrointestinal Cancer Drugs Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Gastrointestinal Cancer Drugs Company Profiles and Sales Data
3.1 Amgen Limited & Amgen Ireland Limited
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
3.1.3 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Bristol-Myers Squibb Company
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
3.2.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 F. Hoffmann-La Roche Ltd.
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
3.3.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Eli Lilly and Company
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
3.4.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Johnson & Johnson Private Limited
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
3.5.3 Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 GlaxoSmithKline plc.
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
3.6.3 GlaxoSmithKline plc. Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Celgene Corporation
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
3.7.3 Celgene Corporation Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Pfizer Inc.
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
3.8.3 Pfizer Inc. Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Sanofi
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
3.9.3 Sanofi Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 Novartis AG
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Gastrointestinal Cancer Drugs Product Category, Application and Specification
3.10.3 Novartis AG Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
4 Gastrointestinal Cancer Drugs Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Gastrointestinal Cancer Drugs Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Gastrointestinal Cancer Drugs Sales and Revenue by Regions
4.2.1 Global Gastrointestinal Cancer Drugs Sales and Market Share by Regions (2014-2019)
4.2.2 Global Gastrointestinal Cancer Drugs Revenue and Market Share by Regions (2014-2019)
4.2.3 Global Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Gastrointestinal Cancer Drugs Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Gastrointestinal Cancer Drugs Application/End Users
5.1 Gastrointestinal Cancer Drugs Segment by Application
5.1.1 Hospitals
5.1.2 Specialized Cancer Treatment Centers
5.1.3 Clinics
5.1.4 Ambulatory Surgical Centers
5.2 Global Gastrointestinal Cancer Drugs Product Segment by Application
5.2.1 Global Gastrointestinal Cancer Drugs Sales by Application
5.2.2 Global Gastrointestinal Cancer Drugs Sales and Market Share by Application (2014-2019)
6 Global Gastrointestinal Cancer Drugs Market Forecast
6.1 Global Gastrointestinal Cancer Drugs Sales, Revenue Forecast (2019-2025)
6.1.1 Global Gastrointestinal Cancer Drugs Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global Gastrointestinal Cancer Drugs Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Gastrointestinal Cancer Drugs Forecast by Regions
6.2.1 North America Gastrointestinal Cancer Drugs Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Gastrointestinal Cancer Drugs Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Gastrointestinal Cancer Drugs Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Gastrointestinal Cancer Drugs Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Gastrointestinal Cancer Drugs Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Gastrointestinal Cancer Drugs Forecast by Type
6.3.1 Global Gastrointestinal Cancer Drugs Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Oncology Gowth Forecast
6.3.3 Radiology Gowth Forecast
6.4 Gastrointestinal Cancer Drugs Forecast by Application
6.4.1 Global Gastrointestinal Cancer Drugs Sales Forecast by Application (2019-2025)
6.4.2 Global Gastrointestinal Cancer Drugs Forecast in Hospitals
6.4.3 Global Gastrointestinal Cancer Drugs Forecast in Specialized Cancer Treatment Centers
7 Gastrointestinal Cancer Drugs Upstream Raw Materials
7.1 Gastrointestinal Cancer Drugs Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Gastrointestinal Cancer Drugs Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
